Benjamin Li

2.6k total citations
132 papers, 1.5k citations indexed

About

Benjamin Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benjamin Li has authored 132 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 25 papers in Molecular Biology. Recurrent topics in Benjamin Li's work include Advances in Oncology and Radiotherapy (24 papers), Advanced Breast Cancer Therapies (23 papers) and Advanced Radiotherapy Techniques (19 papers). Benjamin Li is often cited by papers focused on Advances in Oncology and Radiotherapy (24 papers), Advanced Breast Cancer Therapies (23 papers) and Advanced Radiotherapy Techniques (19 papers). Benjamin Li collaborates with scholars based in United States, Germany and United Kingdom. Benjamin Li's co-authors include Peter B. Dervan, Nicholas G. Nickols, Nader N. Youssef, Fei Yang, Ulrich‐Frank Pape, Ken Fujioka, Palle Bekker Jeppesen, Simon Gabe, Lynn McRoy and Rachel M. Layman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Benjamin Li

107 papers receiving 1.4k citations

Peers

Benjamin Li
Andrew R. Clamp United Kingdom
Lucille Leong United States
Robert Carr United Kingdom
Zvonko Kusić Croatia
D K Kelleher Germany
Akira Mori Japan
Antonio Gutiérrez Spain
Rita A. Blanchard United States
Shingo Hatakeyama Japan
Thomas Mairinger Germany
Andrew R. Clamp United Kingdom
Benjamin Li
Citations per year, relative to Benjamin Li Benjamin Li (= 1×) peers Andrew R. Clamp

Countries citing papers authored by Benjamin Li

Since Specialization
Citations

This map shows the geographic impact of Benjamin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Li more than expected).

Fields of papers citing papers by Benjamin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Li. The network helps show where Benjamin Li may publish in the future.

Co-authorship network of co-authors of Benjamin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Li. A scholar is included among the top collaborators of Benjamin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Li. Benjamin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oikonomidou, Olga, Mark Beresford, Rohan Parikh, et al.. (2025). Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2− advanced breast cancer in Europe. Breast Cancer Research and Treatment. 213(3). 299–312.
3.
4.
Robert, Nicholas J., Connie Chen, Sindy Kim, et al.. (2024). Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer. Future Oncology. 20(12). 761–780. 1 indexed citations
5.
Barata, Pedro C., et al.. (2024). Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer. JAMA Oncology. 10(7). 975–975. 7 indexed citations
6.
Dent, Susan, Avirup Guha, Stella Stergiopoulos, et al.. (2024). Abstract PO1-04-13: CARDIAC-STAR: Prevalence of Cardiovascular Comorbidities in Hormone Receptor Positive Human Epidermal Growth Factor Negative metaStatic breasT cAnceR. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
7.
Li, Benjamin, et al.. (2024). Stereotactic radiotherapy: An educational narrative review. SHILAP Revista de lepidopterología. 8(1). 47–58. 1 indexed citations
8.
Bauman, Jessica R., Geoffrey Liu, Isabel R. Preeshagul, et al.. (2024). Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer. Lung Cancer. 195. 107919–107919. 2 indexed citations
9.
10.
Rugo, Hope S., Xianchen Liu, Benjamin Li, et al.. (2023). Real‐world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database. International Journal of Cancer. 154(4). 701–711. 9 indexed citations
11.
Li, Benjamin, et al.. (2023). Evolving practice in global healthcare: Remote physics support for low‐ and middle‐income countries. Journal of Applied Clinical Medical Physics. 24(3). e13914–e13914. 3 indexed citations
12.
Li, Benjamin, et al.. (2023). Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing. International Journal of Radiation Oncology*Biology*Physics. 115(5). 1205–1216. 2 indexed citations
13.
Ndumbalo, Jerry, Dong Joo Rhee, Benjamin Li, et al.. (2023). Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting. JCO Global Oncology. 9(9). e2300050–e2300050. 1 indexed citations
14.
Li, Benjamin, et al.. (2023). Substance-Induced Psychotic Disorder. Psychiatric Annals. 53(4). 166–170.
15.
Patt, Debra A., Xianchen Liu, Benjamin Li, et al.. (2022). Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis. Clinical Breast Cancer. 22(6). 601–610. 16 indexed citations
16.
Sarria, Gustavo R., et al.. (2022). Longitudinal Remote SBRT/SRS Training in Latin America: A Prospective Cohort Study. Frontiers in Oncology. 12. 851849–851849. 5 indexed citations
17.
Yatabe, Yasushi, Koichi Matsumura, Kanae Togo, et al.. (2020). Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan. JTO Clinical and Research Reports. 2(3). 100136–100136. 9 indexed citations
18.
Li, Benjamin, Gustavo R. Sarria, Bertha García, et al.. (2020). Impact of a SBRT/SRS longitudinal telehealth training pilot course in Latin America. Critical Reviews in Oncology/Hematology. 154. 103072–103072. 8 indexed citations
19.
Nickols, Nicholas G., Jerzy O. Szablowski, Amanda E. Hargrove, et al.. (2013). Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element. Molecular Cancer Therapeutics. 12(5). 675–684. 35 indexed citations
20.
Chu, Quyen D., et al.. (2008). Hypoxia induces CXCR4 overexpression in pancreatic cancer cells. Cancer Research. 68. 4472–4472. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew R. Clamp Breakdown of academic impact, for papers by Lucille Leong Breakdown of academic impact, for papers by Robert Carr Breakdown of academic impact, for papers by Zvonko Kusić Breakdown of academic impact, for papers by D K Kelleher Breakdown of academic impact, for papers by Akira Mori Breakdown of academic impact, for papers by Antonio Gutiérrez Breakdown of academic impact, for papers by Rita A. Blanchard Breakdown of academic impact, for papers by Shingo Hatakeyama Breakdown of academic impact, for papers by Thomas Mairinger
Rankless by CCL
2026